IFIH1 and interstitial lung disease: The majority of patients with anti-Jo1 or anti-MDA5 ab in the current work had ILD (88% of anti-Jo1, 72% in anti-MDA5), and these two antibody subgroups showed higher CAM levels compared to anti-TIF1 \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\:\gamma\:$$\end{document}+ patients or controls.